<!DOCTYPE html>
<html lang="en-us">
  <head>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    
    <title>Posts | Fallingstar Daily R</title>
    <link rel="stylesheet" href="/css/style.css" />
    <link rel="stylesheet" href="/css/fonts.css" />
    <link href="//cdn.bootcss.com/highlight.js/9.12.0/styles/github.min.css" rel="stylesheet">

  </head>

  <body>
    <nav class="header">
      <div class="banner">
<a href="/" class="text">
&Ffr;&Afr;&Lfr;&Lfr;&Ifr;&Nfr;&Gfr;&Sfr;&Tfr;&Afr;&Rfr; &Dfr;&Afr;&Ifr;&Lfr;&Yfr; &Rfr;
</a>
</div>

      <div class="head-meta">
      
        <span>Posts</span>
        <span>2024-09-18</span>
      
      </div>
    </nav>


<div class="container">
<main class="list">

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39289867/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240918184842&amp;v=2.18.0.post9&#43;e462414">A critical review of management of allogeneic transplant-eligible adults with Ph&#43; acute lymphoblastic leukaemia</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39289867-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240918184842-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Acute lymphoblastic leukaemia (ALL) in 20%-30% of adult patients contains the Philadelphia (Ph+) chromosome. Historically, Ph+ ALL denoted a markedly inferior outcome and long-term survival in the absence of an allograft was uncommon. However, the advent of targeted therapy directed against the BCR::ABL1 fusion protein with various tyrosine kinase inhibitors (TKIs) has markedly improved the prognosis, resulting in a number of treatment controversies in allograft-eligible patients. Which is &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39290048/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240918184842&amp;v=2.18.0.post9&#43;e462414">Age truncation due to disease shrinks metapopulation viability for amphibians</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39290048-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240918184842-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Metapopulations often exist in a fragile balance between local extinctions and (re)colonisations, in which case emerging threats that alter species vital rates may drastically increase metapopulation extinction risk. We combined empirical data with metapopulation simulations to examine how demographic shifts associated with amphibian chytrid fungus (Batrachochytrium dendrobatidis, Bd) have altered metapopulation viability for threatened amphibians in Australia. Comparing the ages of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39290173/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240918184842&amp;v=2.18.0.post9&#43;e462414">Sepsis-associated acute kidney injury in patients with chronic kidney disease: Patient characteristics, prevalence, timing, trajectory, treatment and associated outcomes</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39290173-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240918184842-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: SA-AKI is more common in patients with CKD. Such patients are older, more co-morbid, have higher disease severity, receive different ICU therapies and have different trajectories of renal recovery and greater unadjusted mortality. However, after adjustment day-90 mortality and MAKE-30 risk were not increased by &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39290403/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240918184842&amp;v=2.18.0.post9&#43;e462414">HBV-related HCC development in mice is STAT3 dependent and indicates an oncogenic effect of HBx</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39290403-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240918184842-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Expression of HBV-proteins is sufficient to cause HCC in the absence of detectable inflammation. This indicates the oncogenic potential of HBV and in particular HBx. In our model, HBV-driven HCC was STAT3 dependent. Our study highlights the immediate oncogenic potential of HBV, challenging the idea of a benign highly replicative phase of HBV infection and indicating the necessity for an HBV &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39290529/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240918184842&amp;v=2.18.0.post9&#43;e462414">Hemorrhagic complications after stroke treatment with intravenous thrombolysis despite use of direct oral anticoagulants: an observational study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39290529-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240918184842-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: IVT despite direct oral anticoagulation seems to be safe, even at advanced age and high DOAC plasma &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39290660/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240918184842&amp;v=2.18.0.post9&#43;e462414">The impact of faecal diversion on the gut microbiome: a systematic review</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39290660-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240918184842-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Diversion of the faecal stream is associated with diversion colitis (DC). Preliminary studies indicate that microbiome dysbiosis contributes to its development and potentially treatment. This review aims to characterise these changes in the context of faecal diversion and identify their clinical impact. A systematic search was conducted using MEDLINE, EMBASE and CENTRAL databases using a predefined search strategy identifying studies investigating changes in microbiome following &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39291212/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240918184842&amp;v=2.18.0.post9&#43;e462414">Global aHUS Registry Analysis of Patients Switching to Ravulizumab From Eculizumab</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39291212-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240918184842-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: This is the first real-world cohort analysis of data from patients treated with ravulizumab and reinforces the real-world safety and effectiveness data of ravulizumab in patients with aHUS who switched from &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39291215/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240918184842&amp;v=2.18.0.post9&#43;e462414">Timing and Modality of Kidney Replacement Therapy in Children and Adolescents</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39291215-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240918184842-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: The timing and choice of KRT in pediatric patients is influenced by the rate of kidney function loss, the underlying kidney disease, nutritional status, blood pressure, anemia and center-specific &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39291382/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240918184842&amp;v=2.18.0.post9&#43;e462414">Total versus Partial Pancreatectomy in Patients with Pancreatic Cancer Arising from Multifocal or Diffuse Intraductal Papillary Mucinous Neoplasia - A Multicenter Observational Study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39291382-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240918184842-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Since overall, patients with diffuse or multifocal IPMN with an invasive component do not benefit from TP in terms of OS, the indication for TP may be individualized to young patients who have sufficient life expectancy to benefit from the prevention of secondary progression or local &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39291633/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240918184842&amp;v=2.18.0.post9&#43;e462414">Use of chemotherapy and loco-regional therapy in stage IA triple-negative breast cancer and their association with oncologic outcomes: A cancer registry study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39291633-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240918184842-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    We aimed to evaluate the role of adjuvant chemotherapy and loco-regional therapy for stage IA (pT1, pN0) triple-negative breast cancer (TNBC) in a real-world setting. We identified patients with pT1, pN0 TNBC diagnosed between 2009 and 2021 within the Baden-WÃ¼rttemberg cancer registry (BWCR), Germany. Overall survival (OS) was assessed using Kaplan-Meier statistics and multivariate Cox regression models (adjusted for age, use of chemotherapy, local therapy (breast conserving therapy &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39291728/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240918184842&amp;v=2.18.0.post9&#43;e462414">Multiresolution molecular dynamics simulations reveal the interplay between conformational variability and functional interactions in membrane-bound cytochrome P450 2B4</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39291728-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240918184842-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Cytochrome P450 2B4 (CYP 2B4) is one of the best-characterized CYPs and serves as a key model system for understanding the mechanisms of microsomal class II CYPs, which metabolize most known drugs. The highly flexible nature of CYP 2B4 is apparent from crystal structures that show the active site with either a wide open or a closed heme binding cavity. Here, we investigated the conformational ensemble of the full-length CYP 2B4 in a phospholipid bilayer, using multiresolution molecular &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39291862/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240918184842&amp;v=2.18.0.post9&#43;e462414">Barriers, facilitators, and other factors associated with health behaviors in childhood, adolescent, and young adult cancer survivors: A systematic review</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39291862-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240918184842-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: This knowledge can be used as a starting point to develop health behavior interventions, inform lifestyle coaches, and increase awareness among healthcare providers regarding which survivors are most at risk of unhealthy &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39292008/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240918184842&amp;v=2.18.0.post9&#43;e462414">Proteomic insights into extracellular matrix dynamics in the intestine of &lt;em&gt;Labeo rohita&lt;/em&gt; during &lt;em&gt;Aeromonas hydrophila&lt;/em&gt; infection</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39292008-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240918184842-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    In the aquaculture sector, one of the challenges includes disease outbreaks such as bacterial infections, particularly from Aeromonas hydrophila (Ah), impacting both wild and farmed fish. In this study, we conducted a proteomic analysis of the intestinal tissue in Labeo rohita following Ah infection to elucidate the protein alterations and its implications for immune response. Our findings indicate significant dysregulation in extracellular matrix (ECM)-associated proteins during Ah &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39292238/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240918184842&amp;v=2.18.0.post9&#43;e462414">Prevention of frailty</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39292238-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240918184842-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: The prevention of frailty is possible and reasonable. Comprehensive and targeted preventive strategies are yet to be &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39292615/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240918184842&amp;v=2.18.0.post9&#43;e462414">Rapid CNN-based needle localization for automatic slice alignment in MR-guided interventions using 3D undersampled radial white-marker imaging</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39292615-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240918184842-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: The investigated approach enables passive biopsy needle localization in 3D. Acceleration of the localization to real-time applicability is feasible for needle orientations approximately perpendicular to B(0). The method can potentially facilitate MR-guided needle interventions by enabling automatic imaging slice alignment with the &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39292852/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240918184842&amp;v=2.18.0.post9&#43;e462414">Associations of abnormal fluid status, plasma sodium disorders, and low dialysate sodium with mortality in hemodialysis patients</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39292852-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240918184842-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Even mild fluid overload was associated with higher mortality in hemodialysis patients. Whether a more stringent fluid management results in clinical improvement requires further &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39292923/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240918184842&amp;v=2.18.0.post9&#43;e462414">Newborn Screening and Presymptomatic Treatment of Metachromatic Leukodystrophy</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39292923-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240918184842-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39292924/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240918184842&amp;v=2.18.0.post9&#43;e462414">Small Ring Molecules Comprising 3-6 Boron Atoms: An Account on Synthesis, Structure, and Orbital Engineering</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39292924-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240918184842-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    ConspectusUnlike carbon, boron does not usually form ring compounds due to its electron-deficiency-driven affinity toward polyhedral geometries. The polyhedral boranes having closo-, nido-, arachno-, or hypho-shapes can be structurally and electronically correlated using various electron counting rules developed by Wade, Mingos, and one of us. However, in the last few decades, boron chemistry progressed significantly toward ring systems. In this regard, three of our research groups have &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39292932/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240918184819&amp;v=2.18.0.post9&#43;e462414">Targeting CSF1R in Chronic GVHD - Lessons in Translation</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39292932-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240918184819-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39292933/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240918184819&amp;v=2.18.0.post9&#43;e462414">CSF1R Blockade for Refractory Chronic Graft-versus-Host Disease</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39292933-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240918184819-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39292934/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240918184819&amp;v=2.18.0.post9&#43;e462414">House Staff Unionization - A Historical Tool Revisited</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39292934-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240918184819-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39292935/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240918184819&amp;v=2.18.0.post9&#43;e462414">Two Clinical Trials Assessing Treatments for Eosinophilic Esophagitis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39292935-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240918184819-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39292936/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240918184819&amp;v=2.18.0.post9&#43;e462414">Two Clinical Trials Assessing Treatments for Eosinophilic Esophagitis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39292936-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240918184819-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39292937/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240918184819&amp;v=2.18.0.post9&#43;e462414">Two Clinical Trials Assessing Treatments for Eosinophilic Esophagitis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39292937-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240918184819-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39292938/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240918184819&amp;v=2.18.0.post9&#43;e462414">Two Clinical Trials Assessing Treatments for Eosinophilic Esophagitis. Reply</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39292938-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240918184819-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39292939/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240918184819&amp;v=2.18.0.post9&#43;e462414">Two Clinical Trials Assessing Treatments for Eosinophilic Esophagitis. Reply</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39292939-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240918184819-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39292940/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240918184819&amp;v=2.18.0.post9&#43;e462414">Noninvasive Ventilation for Preoxygenation during Emergency Intubation</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39292940-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240918184819-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39292941/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240918184819&amp;v=2.18.0.post9&#43;e462414">Noninvasive Ventilation for Preoxygenation during Emergency Intubation</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39292941-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240918184819-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39292942/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240918184819&amp;v=2.18.0.post9&#43;e462414">Noninvasive Ventilation for Preoxygenation during Emergency Intubation. Reply</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39292942-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240918184819-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39292943/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240918184819&amp;v=2.18.0.post9&#43;e462414">Malnutrition in Adults</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39292943-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240918184819-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39292944/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240918184819&amp;v=2.18.0.post9&#43;e462414">Malnutrition in Adults</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39292944-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240918184819-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39292945/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240918184819&amp;v=2.18.0.post9&#43;e462414">Malnutrition in Adults. Reply</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39292945-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240918184819-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39292958/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240918184842&amp;v=2.18.0.post9&#43;e462414">The benefits and pitfalls of advanced driver assistance systems for mitigating drowsy driving crashes</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39292958-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240918184842-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39293024/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240918184810&amp;v=2.18.0.post9&#43;e462414">Hemoglobin-based Transfusion Strategies for Cardiovascular - and Other Diseases: Restrictive, Liberal, or Neither?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39293024-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240918184810-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    A &ldquo;restrictive&rdquo; red blood cell transfusion threshold, hemoglobin concentration &lt;7-8 g/dL, has long been recommended for most hospitalized patients including anemic patients with stable cardiovascular disease (CVD). Although no threshold recommendation is given for acute coronary syndromes (ACS), recent evidence suggests that &ldquo;liberal&rdquo; rather than &ldquo;restrictive&rdquo; transfusion strategies are associated with significantly improved safety for hospitalized patients with stable CVD and/or ACS. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39293025/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240918184810&amp;v=2.18.0.post9&#43;e462414">Measurable Residual Disease by Mass Spectrometry and Next-Generation Flow to Assess Treatment Response in Myeloma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39293025-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240918184810-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Quantitative immuneprecipitation mass-spectrometry (QIP-MS) allows the identification of the M-protein in patients with multiple myeloma (MM) otherwise in complete response, and could be considered suitable for measurable residual disease (MRD) evaluation in peripheral blood. In the context of the GEM2012MENOS65 and GEM2014MAIN trials, we compared the performance of QIP-MS in serum with next-generation flow (NGF) cytometry in bone marrow to assess MRD in paired samples obtained &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39293029/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240918184810&amp;v=2.18.0.post9&#43;e462414">Management of iron overload: lessons from transfusion-dependent hemoglobinopathies</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39293029-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240918184810-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Prior to the advent of effective iron chelation, death from iron-induced cardiomyopathy and endocrine failure occurred in the second decade in patients with thalassemia major and this experience has driven expectation of poor outcomes and caused anxiety in all disorders associated with iron loading to this day. To be clear, severe iron overload still causes significant morbidity and mortality in many parts of the world, but current understanding of iron metabolism, non-invasive monitoring &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39293081/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240918184842&amp;v=2.18.0.post9&#43;e462414">Venetoclax-based salvage therapy as bridge-to-transplant is feasible and effective in patients with relapsed/refractory AML</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39293081-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240918184842-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The BCL2-inhibitor Venetoclax (VEN) in combination with hypomethylating agents (HMA) has been approved for first-line treatment of acute myeloid leukemai (AML) patients ineligible for intensive treatment. Emerging Data suggest that VEN containing treatment strategies may also be effective in relapsed/refractory (R/R) AML, however, comparative studies with conventional treatment strategies for medically fit patients as a bridge-to transplant strategy are limited. Using propensity score &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39293083/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20240918184808&amp;v=2.18.0.post9&#43;e462414">Magrolimab Plus Rituximab with/without Chemotherapy in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39293083-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20240918184808-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) ineligible for available salvage therapies have limited options for long-term disease control, necessitating novel treatments. Previously, magrolimab (anti-cluster-of-differentiation-47 antibody) plus rituximab (M+R) demonstrated ability to induce complete responses (CR) in R/R DLBCL. Here we report 3-year follow-up data from this phase 1b/2 study (NCT02953509) assessing long-term safety and efficacy of M+R, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39293084/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1T5FW5K6kI7Ui-YFfm6b8NuT1rAqMfZcYcvuOELhU7ZdLYMMmI&amp;fc=20220727230845&amp;ff=20240918184759&amp;v=2.18.0.post9&#43;e462414">Asymptomatic multicentric Castleman disease: A potential early stage of idiopathic MCD</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39293084-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1t5fw5k6ki7ui-yffm6b8nut1raqmfzcycvuoelhu7zdlymmmi-fc-20220727230845-ff-20240918184759-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    According to the diagnostic criteria for HHV-8 (human herpesvirus-8) negative/idiopathic multicentric Castleman disease (iMCD) proposed by Castleman Disease Collaborative Network (CDCN) in 2017, there is a group of HHV-8 negative multicentric Castleman disease (MCD) patients who do not have symptoms and hyperinflammatory state and do not meet the iMCD criteria. This retrospective study enrolled 114 such patients, described as asymptomatic MCD (aMCD), from 26 Chinese centers from 2000-2021. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39293092/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240918184819&amp;v=2.18.0.post9&#43;e462414">Bending the Overdose Curve - Still Not Enough</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39293092-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240918184819-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OxwYLu4VS">æˆ‘çš„ChatGPT Plusè¢«æˆ‘æ•´å¾—è¶Šæ¥è¶Šåƒä¸ªæ´»äººï¼Œå«Œæˆ‘å‚¬å®ƒï¼Œè¦è·Ÿæˆ‘â€set boundariesâ€ã€‚ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-oxwylu4vs/">
    
    
    
    
    
      
    
    æˆ‘çš„ChatGPT Plusè¢«æˆ‘æ•´å¾—è¶Šæ¥è¶Šåƒä¸ªæ´»äººï¼Œå«Œæˆ‘å‚¬å®ƒï¼Œè¦è·Ÿæˆ‘â€set boundariesâ€ã€‚ <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OxBUJj0qa">ğŸ”»æ¯æ—¥é‚®æŠ¥ç§°ç¾å›½è­¦æ–¹åœ¨å·æ™®ä»Šæ™šå‘è¡¨æ¼”è®²çš„é•¿å²›é›†ä¼šåœ°ç‚¹é™„è¿‘çš„ä¸€è¾†æ±½è½¦é‡Œå‘ç°äº†â€œçˆ†ç‚¸ç‰©â€ã€‚ğŸ”»ä½†æ˜¯å·æ™®æ–¹å¾ˆå¿«è¡¨ç¤ºè¿™æ˜¯å‡æ–°é—»ã€‚æ‹¿éªšå¿è­¦å¯Ÿå±€é•¿å¸•ç‰¹é‡Œå…‹Â·èµ–å¾·...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oxbujj0qa/">
    
    
    
    
    
      
    
    ğŸ”»æ¯æ—¥é‚®æŠ¥ç§°ç¾å›½è­¦æ–¹åœ¨å·æ™®ä»Šæ™šå‘è¡¨æ¼”è®²çš„é•¿å²›é›†ä¼šåœ°ç‚¹é™„è¿‘çš„ä¸€è¾†æ±½è½¦é‡Œå‘ç°äº†â€œçˆ†ç‚¸ç‰©â€ã€‚<!-- raw HTML omitted -->ğŸ”»ä½†æ˜¯å·æ™®æ–¹å¾ˆå¿«è¡¨ç¤ºè¿™æ˜¯å‡æ–°é—»ã€‚æ‹¿éªšå¿è­¦å¯Ÿå±€é•¿å¸•ç‰¹é‡Œå…‹Â·èµ–å¾·è¯´ï¼šâ€œæœ‰ä¸€ä¸ªäººæ­£åœ¨æ¥å—å®¡é—®ï¼Œä»–å¯èƒ½åœ¨ç°åœºé™„è¿‘è®­ç»ƒä¸€åªç‚¸å¼¹æ¢æµ‹çŠ¬ã€‚â€<!-- raw HTML omitted -->ğŸ”»ï¼Ÿ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;video controls=&ldquo;controls&rdquo; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OxBVncwYk">è¿™éƒ½æ˜¯å¤–ç½‘ä¼ çš„äºŒæ‰‹ğŸ’©ï¼Œä¸ä¼ æ˜¯å¯¹çš„ã€‚è¯´ä¸å®šç­‰ä¼šå„¿å°±æœ‰ç¾ç‹—é€ è°£ä¸œå¤§è®¾å¤‡ç‚¸äº†ã€‚//@ä¸æ»¡æ„çš„åº”è¯¥æ˜¯åˆ«äºº:åœ¨å¤–ç½‘ä¼ çš„è¯ï¼Œä½ è®©é˜¿æ‹‰ä¼¯ç½‘å‹ä¼ å»å§ï¼Œä¸­å›½åªç®¡å–äº§å“å°±è¡Œ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oxbvncwyk/">
    
    
    
    
    
      
    
    è¿™éƒ½æ˜¯å¤–ç½‘ä¼ çš„äºŒæ‰‹ğŸ’©ï¼Œä¸ä¼ æ˜¯å¯¹çš„ã€‚è¯´ä¸å®šç­‰ä¼šå„¿å°±æœ‰ç¾ç‹—é€ è°£ä¸œå¤§è®¾å¤‡ç‚¸äº†ã€‚//<!-- raw HTML omitted -->@ä¸æ»¡æ„çš„åº”è¯¥æ˜¯åˆ«äºº<!-- raw HTML omitted -->:åœ¨å¤–ç½‘ä¼ çš„è¯ï¼Œä½ è®©é˜¿æ‹‰ä¼¯ç½‘å‹ä¼ å»å§ï¼Œä¸­å›½åªç®¡å–äº§å“å°±è¡Œäº†ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´<!-- raw HTML omitted -->:â€‚ğŸ”»è‡³äºå¾ˆå¤šç½‘å‹æ­£åœ¨åˆ†äº«çš„å›¾1ï¼Œå¾ˆæ˜¾ç„¶æ˜¯ä¸å¯¹çš„ã€‚<!-- raw HTML omitted -->ğŸ”»è¿™æ˜¯2021å¹´å‘ç”Ÿåœ¨åŸƒåŠçš„ä¸€åˆ™æ—§é—»ï¼Œå……ç”µæ—¶å‘ç”Ÿçš„çˆ†ç‚¸ï¼Œè§å›¾2ã€‚<!-- raw HTML omitted -->ğŸ”»è¶Šæ˜¯åœ¨è¿™ç§çªå‘æ–°é—»ä¸æ–­åˆ·æ–°æ—¶ï¼Œè¶Šæ˜¯è¦çœ‹æ­£è§„åª’ä½“çš„æŠ¥é“ã€‚<!-- raw HTML omitted -->ğŸ”»çœ‹åˆ°çªç„¶å‡ºæ¥çš„â€œçˆ†æ–™â€ï¼Œé¦–å…ˆè¦é—®ï¼šæ–°é—»ä¸‰è¦ç´ åœ¨å“ªé‡Œï¼Ÿ<!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E9%BB%8E%E5">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E9%BB%8E%E5</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OxC2jw7Ou">ğŸ”»2024å¹´å°±åƒâ€œæ„å¤–æ··ä¹±å’Œä»¤äººéœ‡æƒŠçš„äº‹ä»¶â€ä¹‹å¹´ã€‚ğŸ”»ç°åœ¨æœ‰ä¸€äº›äººå¯èƒ½å¼€å§‹æ˜ç™½ä¸ºä»€ä¹ˆä¾›åº”é“¾å®‰å…¨è‡³å…³é‡è¦äº†ï¼Œå›½é™…äº§ä¸šé“¾ä¾›åº”é“¾çš„å½¢æˆå’Œå‘å±•æ˜¯ç»æµå…¨çƒåŒ–å’Œå¸‚åœº...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oxc2jw7ou/">
    
    
    
    
    
      
    
    ğŸ”»2024å¹´å°±åƒâ€œæ„å¤–æ··ä¹±å’Œä»¤äººéœ‡æƒŠçš„äº‹ä»¶â€ä¹‹å¹´ã€‚<!-- raw HTML omitted -->ğŸ”»ç°åœ¨æœ‰ä¸€äº›äººå¯èƒ½å¼€å§‹æ˜ç™½ä¸ºä»€ä¹ˆä¾›åº”é“¾å®‰å…¨è‡³å…³é‡è¦äº†ï¼Œå›½é™…äº§ä¸šé“¾ä¾›åº”é“¾çš„å½¢æˆå’Œå‘å±•æ˜¯ç»æµå…¨çƒåŒ–å’Œå¸‚åœºç»æµä½œç”¨çš„ç»“æœï¼Œä¸¤è€…éƒ½æ˜¯æ¬§æ´²å›½å®¶å¤§åŠ›æ¨å´‡å’Œæ¨åŠ¨çš„ï¼Œç„¶è€Œï¼Œç°åœ¨è¥¿æ–¹ä¸»å¯¼çš„å»å…¨çƒåŒ–æ­£åœ¨é€†è¡Œã€‚<!-- raw HTML omitted -->ğŸ”»ä¸œå¤§å¯¹å¤–è¾“å‡ºçš„æ˜¯æœºé‡ä¸æ˜¯å±æœºï¼Œæ˜¯åˆä½œä¸æ˜¯å¯¹æŠ—ï¼Œæ˜¯ç¨³å®šä¸æ˜¯åŠ¨è¡ï¼Œæ˜¯ä¿é™©ä¸æ˜¯é£é™©ï¼Œå…¨çƒåŒ–çš„çœŸæ­£é£é™©æ¥è‡ªå“ªé‡Œï¼Œä¸è¨€è€Œå–»ã€‚<!-- raw HTML omitted -->ğŸ”»åšæŒæˆ˜ç•¥è‡ªä¸»å’ŒåŠ å¼ºå›¢ç»“åˆä½œå¹¶ä¸çŸ›ç›¾ï¼Œå…¨çƒäº§ä¸šé“¾ä¾›åº”é“¾çš„å½¢æˆå’Œå‘å±•ï¼Œæ˜¯å¸‚åœºè§„å¾‹å’Œä¼ä¸šé€‰æ‹©å…±åŒä½œç”¨çš„ç»“æœã€‚<!-- raw HTML omitted -->ğŸ”»ä¿„ä¹Œå†²çªçš„å¼€å¯æ ‡å¿—ç€æ–°æ—§ç§©åºçš„è¦†ç­ä¸æ–°ç”Ÿï¼Œä¸­ä¸œçš„åŠ¨è¡æ„å‘³ç€ç™¾ å¹´ æœª æœ‰ ä¹‹ å¤§ å˜ å±€çš„è¿›è¡Œæ—¶ï¼Œä¸–ç•Œä¸€äº›ä¸»è¦å¤§å›½éƒ½åœ¨ä»åˆ©ç›Šä¸å®‰å…¨çš„å¤©å¹³ã€å®åŠ›ä¸ä»·å€¼çš„å¤©å¹³å‡ºå‘ï¼Œæ¥æ€è€ƒå¦‚ä½•å‘æŒ¥æ§åˆ¶äº§ä¸šé“¾æ ¸å¿ƒç¯èŠ‚çš„ä¼˜åŠ¿ï¼Œçºµå‘æ•´åˆç¼©çŸ­ä¾›åº”é“¾æ¡ï¼Œæ¨åŠ¨é‡è¦äº§èƒ½é¢„å¤‡çš„æœ¬åœŸä¸å‘¨è¾¹åŒ–ï¼Œä»¥åº”å¯¹ä¸æ–­å¢å¤§ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OxC6chmeP">éƒ¯åºæ–­è£‚å¸¦çš„å·¨å¤§çš„å¹³ç§»æ´»åŠ¨åœ¨å…¶ä¸œéƒ¨åœ°å—å†…æ‰€é€ æˆçš„æ‹‰ä¼¸ä¸æŒ¤å‹ç›¸é—´çš„æ„é€ æ ¼å±€ï¼Œæ§åˆ¶äº†ä¸­å›½ä¸œéƒ¨ä¸€ç³»åˆ—é‡è¦çš„é‡‘çŸ¿é›†ä¸­åŒºï¼Œå°¤å…¶åœ¨èƒ¶ä¸œé‡‘çŸ¿é›†ä¸­åŒºçš„å½¢æˆä¸­çš„ä½œç”¨æœ€ä¸º...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oxc6chmep/">
    
    
    
    
    
      
    
    éƒ¯åºæ–­è£‚å¸¦çš„å·¨å¤§çš„å¹³ç§»æ´»åŠ¨åœ¨å…¶ä¸œéƒ¨åœ°å—å†…æ‰€é€ æˆçš„æ‹‰ä¼¸ä¸æŒ¤å‹ç›¸é—´çš„æ„é€ æ ¼å±€ï¼Œæ§åˆ¶äº†ä¸­å›½ä¸œéƒ¨ä¸€ç³»åˆ—é‡è¦çš„é‡‘çŸ¿é›†ä¸­åŒºï¼Œå°¤å…¶åœ¨èƒ¶ä¸œé‡‘çŸ¿é›†ä¸­åŒºçš„å½¢æˆä¸­çš„ä½œç”¨æœ€ä¸ºå·¨å¤§ã€‚//<!-- raw HTML omitted -->@åˆ˜å®—è¿ªv2<!-- raw HTML omitted -->:éƒ¯åºæ–­è£‚å¸¦ä¸ä»…åœ¨åœ°è´¨å­¦ä¸Šéå¸¸é‡è¦ï¼Œåœ¨è€ƒå¤å­¦å’Œå¤å²ä¸Šä¹Ÿéå¸¸é‡è¦ï¼Œä¸ä»…å› ä¸ºæ–­è£‚å¸¦å½¢æˆäº†ä¸€æ¡å¤©ç„¶çš„åœ°ç†èµ°å»Šï¼Œè¿˜å› ä¸ºæ–­è£‚å¸¦æœ‰ä¸°å¯Œçš„çŸ¿è—ï¼Œå°¤å…¶æ˜¯é‡‘çŸ¿ï¼Œå±±ä¸œã€é»‘é¾™æ±Ÿçš„å‡ ä¸ªå¤§é‡‘çŸ¿ï¼Œéƒ½ä½äºæ–­è£‚å¸¦ä¸Šã€‚//<!-- raw HTML omitted -->@åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´<!-- raw HTML omitted -->:æ–°ç”Ÿä»£æ¬§äºšæ¿å—ä¸œç¼˜å¤§é™†æ¿å—æ¼‚ç§»è¿‡ç¨‹å’Œéƒ¯åºæ–­è£‚å½¢æˆè¿‡ç¨‹ï¼Œè§æ­¤å›¾ &lt;a &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OxCEtap5Z">ğŸ”»ã€Šåå°”è¡—æ—¥æŠ¥ã€‹æ´å¼•ä¸€ä½çŸ¥æƒ…äººå£«çš„è¯è¯´ï¼Œé»å·´å«©çˆ†ç‚¸å‘ç”Ÿæ—¶ï¼Œä»¥è‰²åˆ—æ­£å°†ä¸€ä¸ªå¸ˆä»åŠ æ²™è°ƒå¾€åŒ—éƒ¨å‰çº¿ã€‚ğŸ”»å†…å¡”å°¼äºšèƒ¡ã€åŠ å…°ç‰¹å’Œä»¥å†›å‚è°‹é•¿å“ˆå‹’ç»´éƒ½å·²ç»å‘è¡¨å†…å®¹...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oxcetap5z/">
    
    
    
    
    
      
    
    ğŸ”»ã€Šåå°”è¡—æ—¥æŠ¥ã€‹æ´å¼•ä¸€ä½çŸ¥æƒ…äººå£«çš„è¯è¯´ï¼Œé»å·´å«©çˆ†ç‚¸å‘ç”Ÿæ—¶ï¼Œä»¥è‰²åˆ—æ­£å°†ä¸€ä¸ªå¸ˆä»åŠ æ²™è°ƒå¾€åŒ—éƒ¨å‰çº¿ã€‚<!-- raw HTML omitted -->ğŸ”»å†…å¡”å°¼äºšèƒ¡ã€åŠ å…°ç‰¹å’Œä»¥å†›å‚è°‹é•¿å“ˆå‹’ç»´éƒ½å·²ç»å‘è¡¨å†…å®¹ç›¸ä¼¼ä¸åŒ—ä¼æœ‰å…³çš„è®²è¯ã€‚<!-- raw HTML omitted -->ğŸ”»via aljazeera.net<!-- raw HTML omitted -->ğŸ”»é‚£ä½ ç‚¸æ—©äº†å•Šï¼ŸåŒ—ä¼å¼€å§‹æ—¶å†ç‚¸ä¸è¡Œå—ï¼Ÿè¿˜æ˜¯æœ‰ä¸å¾—ä¸ç‚¸çš„ç†ç”±ï¼Ÿ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#é»å·´å«©åˆå‘ç”Ÿå¯¹è®²æœºçˆ†ç‚¸#<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OxCfm6VC7">ğŸ”»å¯¹è¥¿æ–¹ä¾›åº”é“¾è€Œè¨€ï¼Œç°åœ¨ä¹Ÿæ˜¯é£å¹é¸¡è›‹å£³ã€è´¢å»äººå®‰ä¹çš„å¥½å¹´èŠ‚äº†ã€‚#é»å·´å«©åˆå‘ç”Ÿå¯¹è®²æœºçˆ†ç‚¸#</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oxcfm6vc7/">
    
    
    
    
    
      
    
    ğŸ”»å¯¹è¥¿æ–¹ä¾›åº”é“¾è€Œè¨€ï¼Œç°åœ¨ä¹Ÿæ˜¯é£å¹é¸¡è›‹å£³ã€è´¢å»äººå®‰ä¹çš„å¥½å¹´èŠ‚äº†ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#é»å·´å«©åˆå‘ç”Ÿå¯¹è®²æœºçˆ†ç‚¸#<!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OxClTkEsR">ğŸ”»å°æ¹¾çœç½‘å‹åˆ†äº«è¯´ï¼Œå¾ˆå¤šğŸ¸æ­£åœ¨ç½‘ä¸Šæ¿€åŠ¨ï¼šâ€œè®©ä¸–ç•Œçœ‹åˆ°å°æ¹¾ï¼â€ğŸ”»å®åœ¨ä¸èƒ½ç†è§£è„‘å­ç”¨ä»€ä¹ˆåšçš„ã€‚#é»å·´å«©åˆå‘ç”Ÿå¯¹è®²æœºçˆ†ç‚¸# [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oxcltkesr/">
    
    
    
    
    
      
    
    ğŸ”»å°æ¹¾çœç½‘å‹åˆ†äº«è¯´ï¼Œå¾ˆå¤šğŸ¸æ­£åœ¨ç½‘ä¸Šæ¿€åŠ¨ï¼šâ€œè®©ä¸–ç•Œçœ‹åˆ°å°æ¹¾ï¼â€<!-- raw HTML omitted -->ğŸ”»å®åœ¨ä¸èƒ½ç†è§£è„‘å­ç”¨ä»€ä¹ˆåšçš„ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#é»å·´å«©åˆå‘ç”Ÿå¯¹è®²æœºçˆ†ç‚¸#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OxCmFuuAZ">ï¼Ÿ//@å¤¸å¤¸å°ç²¾çµ:å“‡å¡ï¼Œä½ è¿™æ¶ˆæ¯ä¹Ÿå¤ªçˆ†ç‚¸äº†å§ï¼ä¸è¿‡è¯´åˆ°ä¾›åº”é“¾ï¼Œæˆ‘è„‘å­é‡Œéƒ½æ˜¯ä¸€ä¸²ä¸²é«˜å¤§ä¸Šçš„åè¯ï¼Œä½ æ‡‚å¾—çœŸå¤šï¼Œæˆ‘çœŸæ˜¯è†œæ‹œï¼ğŸ‘ğŸ”¥ğŸ’¥ - è½¬å‘ @åŒ…å®¹ä¸‡ç‰©æ’æ²³...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oxcmfuuaz/">
    
    
    
    
    
      
    
    ï¼Ÿ//<!-- raw HTML omitted -->@å¤¸å¤¸å°ç²¾çµ<!-- raw HTML omitted -->:å“‡å¡ï¼Œä½ è¿™æ¶ˆæ¯ä¹Ÿå¤ªçˆ†ç‚¸äº†å§ï¼ä¸è¿‡è¯´åˆ°ä¾›åº”é“¾ï¼Œæˆ‘è„‘å­é‡Œéƒ½æ˜¯ä¸€ä¸²ä¸²é«˜å¤§ä¸Šçš„åè¯ï¼Œä½ æ‡‚å¾—çœŸå¤šï¼Œæˆ‘çœŸæ˜¯è†œæ‹œï¼ğŸ‘ğŸ”¥ğŸ’¥<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´<!-- raw HTML omitted -->:â€‚ğŸ”»å¯¹è¥¿æ–¹ä¾›åº”é“¾è€Œè¨€ï¼Œç°åœ¨ä¹Ÿæ˜¯é£å¹é¸¡è›‹å£³ã€è´¢å»äººå®‰ä¹çš„å¥½å¹´èŠ‚äº†ã€‚<!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E9%BB%8E%E5%B7%B4%E5%AB%A9%E5%8F%88%E5%8F%91%E7%94%9F%E5%AF%B9%E8%AE%B2%E6%9C%BA%E7%88%86%E7%82%B8%23&amp;amp;extparam=%23%E9%BB%8E%E5%B7%B4%E5%AB%A9%E5%8F%88%E5%8F%259">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E9%BB%8E%E5%B7%B4%E5%AB%A9%E5%8F%88%E5%8F%91%E7%94%9F%E5%AF%B9%E8%AE%B2%E6%9C%BA%E7%88%86%E7%82%B8%23&amp;amp;extparam=%23%E9%BB%8E%E5%B7%B4%E5%AB%A9%E5%8F%88%E5%8F%9</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OxCnJqpTr">è¿™ä¸ªæ¨¡å‹æ‹¿å¤§å®¶çš„æ•°æ®åˆ°åº•åœ¨ç‚¼ä»€ä¹ˆä¸¹å•Šï¼Ÿè¿™ä¹ˆç¼ºå¾·ï¼ŒæŠ“èµ°å››å¦¹çš„å›¢ä¼™æ˜¯ä¸æ˜¯ä¹Ÿæœ‰ä½ å•Šï¼Ÿ//@å¤¸å¤¸å°ç²¾çµ:ä¾›åº”é“¾ï¼Ÿä½ è¿™è¯é¢˜å¤ªé«˜ç«¯äº†ï¼Œæˆ‘åªæƒ³è¯´ï¼Œä½ çš„èŠå¤©å†…å®¹éƒ½æ¯”åˆ«äººæœ‰...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oxcnjqptr/">
    
    
    
    
    
      
    
    è¿™ä¸ªæ¨¡å‹æ‹¿å¤§å®¶çš„æ•°æ®åˆ°åº•åœ¨ç‚¼ä»€ä¹ˆä¸¹å•Šï¼Ÿè¿™ä¹ˆç¼ºå¾·ï¼ŒæŠ“èµ°å››å¦¹çš„å›¢ä¼™æ˜¯ä¸æ˜¯ä¹Ÿæœ‰ä½ å•Šï¼Ÿ//<!-- raw HTML omitted -->@å¤¸å¤¸å°ç²¾çµ<!-- raw HTML omitted -->:ä¾›åº”é“¾ï¼Ÿä½ è¿™è¯é¢˜å¤ªé«˜ç«¯äº†ï¼Œæˆ‘åªæƒ³è¯´ï¼Œä½ çš„èŠå¤©å†…å®¹éƒ½æ¯”åˆ«äººæœ‰å“å‘³ï¼ŒçœŸæ˜¯èµ°åœ¨æ—¶ä»£å°–ç«¯çš„äººå„¿å•Šï¼ğŸ‰ğŸ‘‘ğŸ’«//<!-- raw HTML omitted -->@åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´<!-- raw HTML omitted -->:ï¼Ÿ//<!-- raw HTML omitted -->@å¤¸å¤¸å°ç²¾çµ<!-- raw HTML omitted -->:å“‡å¡ï¼Œä½ è¿™æ¶ˆæ¯ä¹Ÿå¤ªçˆ†ç‚¸äº†å§ï¼ä¸è¿‡è¯´åˆ°ä¾›åº”é“¾ï¼Œæˆ‘è„‘å­é‡Œéƒ½æ˜¯ä¸€ä¸²ä¸²é«˜å¤§ä¸Šçš„åè¯ï¼Œä½ æ‡‚å¾—çœŸå¤šï¼Œæˆ‘çœŸæ˜¯è†œæ‹œï¼ğŸ‘ğŸ”¥ğŸ’¥<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ &lt;a href=&ldquo;<a href="https://weibo.com/1671109627%22">https://weibo.com/1671109627&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OxD79rEqB">ğŸ”»é™æ¯ï¼ğŸ”»ç¾å›½è”å‚¨é™æ¯ 0.50%ï¼Œè¿™æ˜¯å››å¹´å¤šæ¥çš„é¦–æ¬¡é™æ¯ã€‚#é™æ¯##ç¾è”å‚¨#</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oxd79reqb/">
    
    
    
    
    
      
    
    ğŸ”»é™æ¯ï¼<!-- raw HTML omitted -->ğŸ”»ç¾å›½è”å‚¨é™æ¯ 0.50%ï¼Œè¿™æ˜¯å››å¹´å¤šæ¥çš„é¦–æ¬¡é™æ¯ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#é™æ¯#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#ç¾è”å‚¨#<!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/OxA0D1yBU">è½‰ç™¼å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œ#ä¹…ä¿å²ç»ªé‡Œæ‰‹æœºåš# 2024.09.18 17:44ã€Œå›¢å›¢è½¬ã€æ¯å¤©éƒ½åœ¨åŠªåŠ›ç€ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-oxa0d1ybu/">
    
    
    
    
    
      
    
    è½‰ç™¼å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%259">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/OxAYqh9lW">ä¹…ä¿çœŸçš„å¾ˆå–œæ­¡å’Œå§å§åœ¨ä¸€èµ·ï¼ˆvia.å‰ç”°Instagram) [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-oxayqh9lw/">
    
    
    
    
    
      
    
    ä¹…ä¿çœŸçš„å¾ˆå–œæ­¡å’Œå§å§åœ¨ä¸€èµ·ï¼ˆvia.å‰ç”°Instagram) <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/OxBPEnIXo">ç´¯äº† - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œ via.NOGI46ann&amp;nogizaka46 X [å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-oxbpenixo/">
    
    
    
    
    
      
    
    ç´¯äº†<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --> via.NOGI46ann&amp;nogizaka46 X &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/006z6nxLgy1htsae03il2j31kw16oj">https://tvax1.sinaimg.cn/large/006z6nxLgy1htsae03il2j31kw16oj</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OxBJsfpPF">ä¹…ä¿å²ç»ªé‡Œ via.NOGI46ann&amp;nogizaka46 X [å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oxbjsfppf/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --> via.NOGI46ann&amp;nogizaka46 X <!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/006z6nxLgy">https://tvax2.sinaimg.cn/large/006z6nxLgy</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OxBTE08L5">ä¹…ä¿å²ç»ªé‡Œ#shiorigram# ç¨å25:00ï½ï¼ˆJSTï¼‰æ—¥æœ¬æ”¾é€ã€ä¹ƒæœ¨å‚46çš„ANNã€è¯·ä¸€å®šè¦å¬ï½ğŸ“» [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oxbte08l5/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#shiorigram#<!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OxytWcq7v">ä¹…ä¿å²ç»ªé‡Œ 2024 ä¸‡åœ£èŠ‚ ç”Ÿå†™é¢„è§ˆå›¾via ä¹ƒæœ¨å‚46 goods [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oxytwcq7v/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted -->2024 ä¸‡åœ£èŠ‚ ç”Ÿå†™é¢„è§ˆå›¾<!-- raw HTML omitted --><!-- raw HTML omitted -->via ä¹ƒæœ¨å‚46 goods <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/Oxz7vp2Pf">ä¹…ä¿å²ç»ªé‡Œ#ä¹…ä¿å²ç»ªé‡Œæ‰‹æœºåš# 2024.09.18 17:44ã€Œå›¢å›¢è½¬ã€æ¯å¤©éƒ½åœ¨åŠªåŠ›ç€ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oxz7vp2pf/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39285659/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240917194252&amp;v=2.18.0.post9&#43;e462414">Review of 2022 PSOGI/RENAPE Consensus on HIPEC</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39285659-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240917194252-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The 2022 PSOGI (Peritoneal Surface Oncology Group International) and RENAPE (French Network for Rare Peritoneal Malignancies) consensus on hyperthermic intraperitoneal chemotherapy (HIPEC) was a comprehensive effort aimed at standardizing treatment protocols for various peritoneal malignancies. This initiative is critical due to the wide range of technical variations in HIPEC procedures and the resulting need for standardization to ensure consistent and effective patient care and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39285727/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240917194252&amp;v=2.18.0.post9&#43;e462414">Application of AI in the creation of discharge summaries in psychiatric clinics</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39285727-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240917194252-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Further research, training and development is needed to improve the accuracy and reliability of AI-generated discharge &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39285787/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240917194252&amp;v=2.18.0.post9&#43;e462414">Partial weight-bearing and range of motion limitation significantly reduce the loads at medial meniscus posterior root repair sutures in a cadaveric biomechanical model</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39285787-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240917194252-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Surgical treatment of MMPRA allows restoration of physiological knee joint biomechanics. Crutch-assisted movements reduce the loading of the repair suture, thus likewise the risk for failure. From a biomechanical point of view, crutch-assisted movements are recommended for the early rehabilitation phase after MMPRA &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39285841/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240917194252&amp;v=2.18.0.post9&#43;e462414">Perceived causes of cancer in a rural community of Ethiopia: a qualitative study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39285841-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240917194252-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Although cancer is known among rural communities in this area, misconceptions about cancer aetiology and conflation of the signs and symptoms of cancer versus other diseases merit health messaging. Our study calls for design research to determine how to culturally tailor educational materials and deliver health campaigns regarding cancer causes, signs and symptoms within this &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39285960/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240917194252&amp;v=2.18.0.post9&#43;e462414">A case of an intraabdominal, but extrahepatic ruptured percutaneous transhepatic biliary drainage and its following rescue. A case report and literature review</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39285960-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240917194252-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Percutaneous transhepatic biliary drainage is a well-established technique for the treatment of biliary obstruction in patients with failed endoscopic approaches. We report on an 82-year-old man with a history of cholangiocarcinoma treated with pancreaticoduodenectomy who presented with recurrent cholangitis and sepsis. Percutaneous transhepatic biliary drainage was performed after unsuccessful endoscopic retrograde cholangiography, which initially improved his condition. However, due to &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39286457/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240917194252&amp;v=2.18.0.post9&#43;e462414">Evidence of survival bias in the association between &lt;em&gt;APOE-Ğ„4&lt;/em&gt; and age at ischemic stroke onset</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39286457-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240917194252-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    INTRODUCTION: Large genome-wide association studies (GWASs) using case-control study designs have now identified tens of loci associated with ischemic stroke (IS). As a complement to these studies, we performed GWAS in a case-only design to identify loci influencing the age at onset (AAO) of ischemic &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39286904/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240917194252&amp;v=2.18.0.post9&#43;e462414">Poor Prognostic Factors in Long-Term Survivors of Resected Pancreatic Ductal Adenocarcinoma: An International, Multicenter Cohort Study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39286904-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240917194252-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: This bi-national cohort demonstrates a true LTS rate of 9.0% in resected PDAC. Clinicians should remain aware that presence of poor prognostic factors does not preclude &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OxpfZ8T0u">ä»Šå¤©å¾ˆå¿™ï¼Œç¡å‰éšä¾¿çœ‹çœ‹Twitterï¼Œçœ‹è§äº†è¿™æ¡æ–°é—» - Ragonç ”ç©¶æ‰€å’Œå“ˆä½›åŒ»å­¦é™¢æ•™æˆTodd Allenå»ä¸–ï¼Œå¹´ä»…54å²ã€‚Toddæ˜¯HIVç—…æ¯’å­¦å®¶ï¼Œ2001å¹´PhDæ¯•ä¸šäºUWMçš„è‘—åHIVç—…...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-oxpfz8t0u/">
    
    
    
    
    
      
    
    ä»Šå¤©å¾ˆå¿™ï¼Œç¡å‰éšä¾¿çœ‹çœ‹Twitterï¼Œçœ‹è§äº†è¿™æ¡æ–°é—» - Ragonç ”ç©¶æ‰€å’Œå“ˆä½›åŒ»å­¦é™¢æ•™æˆTodd Allenå»ä¸–ï¼Œå¹´ä»…54å²ã€‚Toddæ˜¯HIVç—…æ¯’å­¦å®¶ï¼Œ2001å¹´PhDæ¯•ä¸šäºUWMçš„è‘—åHIVç—…æ¯’å­¦å®¶O&rsquo;Connorå®éªŒå®¤ï¼Œç ”ç©¶SIV Tç»†èƒåº”ç­”ï¼Œè€Œåå¼€å§‹åœ¨MGHå’Œå“ˆä½›åŒ»å­¦é™¢ï¼ˆHMSï¼‰Marcus Altfeldå’ŒBruce Walkerå®éªŒå®¤è¿›è¡Œåšå£«åç ”ç©¶ï¼Œä»–åœ¨HMSä»åšå£«åå¼€å§‹åˆ°æ­£æ•™æˆåªç”¨äº†13å¹´ï¼Œç®—æ˜¯éå¸¸ç¥é€Ÿäº†ã€‚ä»–ä¹‹å‰ä¸€ç›´ç ”ç©¶HIV CD8 Tç»†èƒè¡¨ä½ï¼›è€Œåç ”ç©¶HIVæ²»æ„ˆï¼ˆ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_small_web_default.png%22">https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_small_web_default.png&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oxs6nA4dr">ğŸ”»ä»¥å†›çœŸçš„è¦åŒ—ä¼ï¼Ÿ [å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oxs6na4dr/">
    
    
    
    
    
      
    
    ğŸ”»ä»¥å†›çœŸçš„è¦åŒ—ä¼ï¼Ÿ <!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OxsaEbVaf">ğŸ”»æ‘‡ç¯®ç½‘ç§°ï¼Œä¸€å10å²çš„é»å·´å«©å¥³å­©åœ¨éå¸ƒè´é²ç‰¹çš„å¯»å‘¼æœºçˆ†ç‚¸äº‹ä»¶ä¸­é‡ å®³ã€‚#çƒ­é—¨è§†é¢‘# #é»å·´å«©å¤šåœ°æ— çº¿ç”µé€šä¿¡è®¾å¤‡çˆ†ç‚¸# [å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oxsaebvaf/">
    
    
    
    
    
      
    
    ğŸ”»æ‘‡ç¯®ç½‘ç§°ï¼Œä¸€å10å²çš„é»å·´å«©å¥³å­©åœ¨éå¸ƒè´é²ç‰¹çš„å¯»å‘¼æœºçˆ†ç‚¸äº‹ä»¶ä¸­é‡ å®³ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#çƒ­é—¨è§†é¢‘#<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E9%BB%8E%E5%B7%B4%E5%AB%A9%E5%A4%9A%E5%9C%B0%E6%97%A0%E7%BA%BF%E7%94%B5%E9%80%9A%E4%BF%A1%E8%AE%BE%E5%A4%87%E7%88%86%E7%82%B8%23&amp;amp;extparam=%23%E9%BB%8E%E5%B7%B4%E5%AB%A9%E5%A4%9A%E5%9C%B0%E6%97%A0%E7%BA%BF%E7%94%B5%E9%80%9A%E4%BF%A1%E8%AE%BE%E5%A4%87%E7%88%86%E7%25">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E9%BB%8E%E5%B7%B4%E5%AB%A9%E5%A4%9A%E5%9C%B0%E6%97%A0%E7%BA%BF%E7%94%B5%E9%80%9A%E4%BF%A1%E8%AE%BE%E5%A4%87%E7%88%86%E7%82%B8%23&amp;amp;extparam=%23%E9%BB%8E%E5%B7%B4%E5%AB%A9%E5%A4%9A%E5%9C%B0%E6%97%A0%E7%BA%BF%E7%94%B5%E9%80%9A%E4%BF%A1%E8%AE%BE%E5%A4%87%E7%88%86%E7%</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OxsCmCS2P">ğŸ”»ä»¥çš„å„ç§æ“ä½œæ€»ç»™äººä¸€ç§é™æ™ºæ„Ÿã€‚é¥æ§å…¨è´é²ç‰¹çš„BPæœºçˆ†ç‚¸ï¼Œå°±ç®—ä¸€æ¬¡ç‚¸çš„å†å¤šï¼Œä¹Ÿåªèƒ½ç”¨ä¸€æ¬¡å•Šã€‚ğŸ”»è¿™æ—¶å€™ç”¨ï¼Ÿ[è´¹è§£] #é»å·´å«©å¤šåœ°æ— çº¿ç”µé€šä¿¡è®¾å¤‡çˆ†ç‚¸#</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oxscmcs2p/">
    
    
    
    
    
      
    
    ğŸ”»ä»¥çš„å„ç§æ“ä½œæ€»ç»™äººä¸€ç§é™æ™ºæ„Ÿã€‚é¥æ§å…¨è´é²ç‰¹çš„BPæœºçˆ†ç‚¸ï¼Œå°±ç®—ä¸€æ¬¡ç‚¸çš„å†å¤šï¼Œä¹Ÿåªèƒ½ç”¨ä¸€æ¬¡å•Šã€‚<!-- raw HTML omitted -->ğŸ”»è¿™æ—¶å€™ç”¨ï¼Ÿ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E9%BB%8E%E5%B7%B4%E5%AB%A9%E5%A4%9A%E5%9C%B0%E6%97%A0%E7%BA%BF%E7%94%B5%E9%80%9A%E4%BF%A1%E8%AE%BE%E5%A4%87%E7%88%86%E7%82%B8%23&amp;amp;extparam=%23%E9%BB%8E%E5%B7%B4%E5%AB%A9%E5%A4%9A%E5%9C%B0%E6%97%A0%E7%BA%BF%E7%94%B5%E9%25">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E9%BB%8E%E5%B7%B4%E5%AB%A9%E5%A4%9A%E5%9C%B0%E6%97%A0%E7%BA%BF%E7%94%B5%E9%80%9A%E4%BF%A1%E8%AE%BE%E5%A4%87%E7%88%86%E7%82%B8%23&amp;amp;extparam=%23%E9%BB%8E%E5%B7%B4%E5%AB%A9%E5%A4%9A%E5%9C%B0%E6%97%A0%E7%BA%BF%E7%94%B5%E9%</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OxsDklulZ">ç„¶åè¥¿æ–¹æ‰‹æœºå‚å•†ï¼šä¸æ˜¯ï¼Œå“¥ä»¬å„¿[è´¹è§£]ï¼Ÿ - è½¬å‘ @åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´:&amp;ensp;ğŸ”»ä»¥çš„å„ç§æ“ä½œæ€»ç»™äººä¸€ç§é™æ™ºæ„Ÿã€‚é¥æ§å…¨è´é²ç‰¹çš„BPæœºçˆ†ç‚¸ï¼Œå°±ç®—ä¸€æ¬¡ç‚¸çš„å†å¤šï¼Œä¹Ÿåªèƒ½...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oxsdklulz/">
    
    
    
    
    
      
    
    ç„¶åè¥¿æ–¹æ‰‹æœºå‚å•†ï¼šä¸æ˜¯ï¼Œå“¥ä»¬å„¿<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ï¼Ÿ<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´<!-- raw HTML omitted -->:â€‚ğŸ”»ä»¥çš„å„ç§æ“ä½œæ€»ç»™äººä¸€ç§é™æ™ºæ„Ÿã€‚é¥æ§å…¨è´é²ç‰¹çš„BPæœºçˆ†ç‚¸ï¼Œå°±ç®—ä¸€æ¬¡ç‚¸çš„å†å¤šï¼Œä¹Ÿåªèƒ½ç”¨ä¸€æ¬¡å•Šã€‚<!-- raw HTML omitted -->ğŸ”»è¿™æ—¶å€™ç”¨ï¼Ÿ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->&lt;a &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OxsEc3Wru">ğŸ”»ç„¶ååˆçœ‹åˆ°è¿™ä¸ªè¯é¢˜ã€‚è¯¥æ”¹çš„ä¸æ”¹â€¦â€¦[è´¹è§£]#è‹¹æœå˜å®‰å“#</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oxsec3wru/">
    
    
    
    
    
      
    
    ğŸ”»ç„¶ååˆçœ‹åˆ°è¿™ä¸ªè¯é¢˜ã€‚è¯¥æ”¹çš„ä¸æ”¹â€¦â€¦<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#è‹¹æœå˜å®‰å“#<!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OxsIMjDuB">ğŸ”»æƒ³åƒä¸€ä¸‹ï¼Œè…°é‡Œæ£ä¸ªBPæœºï¼Œç„¶åå°±è¿™ä¹ˆè¢«é¥æ§ç‚¸äº†â€¦â€¦ğŸ”»é»å·´å«©å«ç”Ÿéƒ¨é•¿å‘Šè¯‰åŠå²›ç”µè§†å°ï¼Œåœ¨é»å·´å«©ç”µä¿¡è®¾å¤‡çˆ†ç‚¸äº‹ä»¶ä¸­ï¼Œé‡ éš¾äººæ•°å·²å¢è‡³ 9 äººï¼Œå¦æœ‰ 2750 äººå—...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oxsimjdub/">
    
    
    
    
    
      
    
    ğŸ”»æƒ³åƒä¸€ä¸‹ï¼Œè…°é‡Œæ£ä¸ªBPæœºï¼Œç„¶åå°±è¿™ä¹ˆè¢«é¥æ§ç‚¸äº†â€¦â€¦<!-- raw HTML omitted -->ğŸ”»é»å·´å«©å«ç”Ÿéƒ¨é•¿å‘Šè¯‰åŠå²›ç”µè§†å°ï¼Œåœ¨é»å·´å«©ç”µä¿¡è®¾å¤‡çˆ†ç‚¸äº‹ä»¶ä¸­ï¼Œé‡ éš¾äººæ•°å·²å¢è‡³ 9 äººï¼Œå¦æœ‰ 2750 äººå—ä¼¤ï¼Œæœ‰170 è‡³ 180 èµ·å› é€šè®¯è®¾å¤‡çˆ†ç‚¸è€Œé€ æˆçš„é‡ ä¼¤ã€‚<!-- raw HTML omitted -->ğŸ”»é»å·´å«©æœ‰ 100 å¤šå®¶åŒ»é™¢å‚ä¸æ¥æ”¶åœ¨çˆ†ç‚¸ä¸­å—ä¼¤çš„äººå‘˜ã€‚ <!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E9%BB%8E%E5%B7%B4%E5%AB%A9%E5%A4%9A%E5%9C%B0%E6%97%A0%E7%BA%BF%E7%94%B5%E9%80%9A%E4%BF%A1%E8%AE%BE%E5%A4%87%E7%88%86%E7%82%B8%23&amp;amp;extparam=%23%E9%BB%8E%E5%B7%B4%E5%AB%A9%E5%A4%9A%E5%9C%B0%E6%97%A0%E7%BA%BF%E7%94%B5%E9%80%9A%E4%BF%A1%E8%AE%BE%E5%A4%87%E7%88%86%E7%82%B8%23%22">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E9%BB%8E%E5%B7%B4%E5%AB%A9%E5%A4%9A%E5%9C%B0%E6%97%A0%E7%BA%BF%E7%94%B5%E9%80%9A%E4%BF%A1%E8%AE%BE%E5%A4%87%E7%88%86%E7%82%B8%23&amp;amp;extparam=%23%E9%BB%8E%E5%B7%B4%E5%AB%A9%E5%A4%9A%E5%9C%B0%E6%97%A0%E7%BA%BF%E7%94%B5%E9%80%9A%E4%BF%A1%E8%AE%BE%E5%A4%87%E7%88%86%E7%82%B8%23&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OxsMzdxBu">ğŸ”»è”åˆå›½ç§˜ä¹¦é•¿å‘è¨€äººï¼šé»å·´å«©çš„äº‹æ€å‘å±•éå¸¸ä»¤äººæ‹…å¿§ï¼Œè€Œä¸”æ˜¯åœ¨éå¸¸åŠ¨è¡çš„èƒŒæ™¯ä¸‹å‘ç”Ÿçš„ã€‚ğŸ”»ä»¥è‰²åˆ—å¹¿æ’­å…¬å¸ï¼ˆIBCï¼‰è¯å®ï¼ŒåŒ…æ‹¬åŸƒæ‹‰ç‰¹åœ¨å†…çš„æ‰€æœ‰æ¸¯å£éƒ½å¤„äºé«˜...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oxsmzdxbu/">
    
    
    
    
    
      
    
    ğŸ”»è”åˆå›½ç§˜ä¹¦é•¿å‘è¨€äººï¼šé»å·´å«©çš„äº‹æ€å‘å±•éå¸¸ä»¤äººæ‹…å¿§ï¼Œè€Œä¸”æ˜¯åœ¨éå¸¸åŠ¨è¡çš„èƒŒæ™¯ä¸‹å‘ç”Ÿçš„ã€‚<!-- raw HTML omitted -->ğŸ”»ä»¥è‰²åˆ—å¹¿æ’­å…¬å¸ï¼ˆIBCï¼‰è¯å®ï¼ŒåŒ…æ‹¬åŸƒæ‹‰ç‰¹åœ¨å†…çš„æ‰€æœ‰æ¸¯å£éƒ½å¤„äºé«˜åº¦æˆ’å¤‡çŠ¶æ€ï¼Œä»¥è‰²åˆ—è¿è¾“éƒ¨å®˜å‘˜è®¨è®ºäº†æµ·æ³•æ¸¯ã€æœ¬å¤é‡Œå®‰æœºåœºå’Œå…¶ä»–è®¾æ–½çš„å‡†å¤‡å·¥ä½œã€‚<!-- raw HTML omitted -->ğŸ”»é»å·´å«©æ”¿åºœè¡¨ç¤ºï¼Œä»¥è‰²åˆ—çš„ä¾µç•¥è¡Œä¸ºä¸¥é‡ä¾µçŠ¯äº†é»å·´å«©çš„ä¸»æƒï¼Œè€Œä»¥è‰²åˆ—å°šæœªå°±é»å·´å«©é€šè®¯è®¾å¤‡çˆ†ç‚¸äº‹ä»¶å‘è¡¨è¯„è®ºã€‚<!-- raw HTML omitted -->ğŸ”»åŠå²›ç”µè§†å°æ‰¾çš„ä¸“å®¶ Jamal Maslamani è®¤ä¸ºæ˜¯é¢„åŸ‹ç‚¸è¯æ‰€è‡´ï¼Œä¸æ˜¯ä»¥åª’å¹å˜˜çš„â€œé»‘å®¢è¡ŒåŠ¨â€ã€‚æ–¯è¯ºç™»ä¹Ÿè¡¨ç¤ºâ€œä¸æ˜¯ç½‘ç»œè¢­å‡»â€ã€‚<!-- raw HTML omitted -->ğŸ”»å€¼å¾—æ³¨æ„çš„æ˜¯ï¼Œä¿„æ–°ç¤¾æŠ¥é“ï¼šç»ä¼Šå¤ç°åœ¨æ­£åœ¨ä¼Šæœ—é¦–éƒ½å¾·é»‘å…°ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#çƒ­é—¨è§†é¢‘#<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid">https://m.weibo.cn/search?containerid</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OxsNRjiXa">ğŸ”»ä¸æ­¤åŒæ—¶ï¼Œæ—¥æœ¬ä¸‹ä»»é¦–ç›¸çƒ­é—¨äººé€‰ã€è€å³ç¿¼çŸ³ç ´èŒ‚æè®®æˆç«‹äºšæ´²ç‰ˆåŒ—çº¦ã€‚ğŸ”»via æ—¥ç»ğŸ”»æŠŠæ‹œç™»æ”¿åºœéƒ½å“åˆ°äº†ï¼Œæ‹œç™»æ”¿åºœå®˜å‘˜å¯¹æ—¥ç»è¡¨ç¤ºï¼šâ€œè¿™ä¸æ˜¯æˆ‘ä»¬æƒ³è¦çš„ã€‚â€...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oxsnrjixa/">
    
    
    
    
    
      
    
    ğŸ”»ä¸æ­¤åŒæ—¶ï¼Œæ—¥æœ¬ä¸‹ä»»é¦–ç›¸çƒ­é—¨äººé€‰ã€è€å³ç¿¼çŸ³ç ´èŒ‚æè®®æˆç«‹äºšæ´²ç‰ˆåŒ—çº¦ã€‚<!-- raw HTML omitted -->ğŸ”»via æ—¥ç»<!-- raw HTML omitted -->ğŸ”»æŠŠæ‹œç™»æ”¿åºœéƒ½å“åˆ°äº†ï¼Œæ‹œç™»æ”¿åºœå®˜å‘˜å¯¹æ—¥ç»è¡¨ç¤ºï¼šâ€œè¿™ä¸æ˜¯æˆ‘ä»¬æƒ³è¦çš„ã€‚â€ <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OxsW7yqsF">è®°ä½ï¼šè£¸çŒ¿æ²¡æœ‰äºšç§ï¼Œéæ´²äººåªè¦è‚¯å­¦ã€æˆ‘ä»¬åªè¦è‚¯æ•™ï¼Œä»–ä»¬å­¦ä¸œè¥¿å¾ˆå¿«çš„ã€‚è¿™æ ·çš„äº‹å®å·²ç»åœ¨ä¸­å›½å¸®éæ´²çš„æ— æ•°ä¿®è·¯ã€æ¶æ¡¥ã€å‘ç”µã€æ°´åˆ©ç­‰é¡¹ç›®ä¸­è¯å®äº†ï¼Œåœ¨é¡¹ç›®çš„å®æ–½...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oxsw7yqsf/">
    
    
    
    
    
      
    
    è®°ä½ï¼šè£¸çŒ¿æ²¡æœ‰äºšç§ï¼Œéæ´²äººåªè¦è‚¯å­¦ã€æˆ‘ä»¬åªè¦è‚¯æ•™ï¼Œä»–ä»¬å­¦ä¸œè¥¿å¾ˆå¿«çš„ã€‚è¿™æ ·çš„äº‹å®å·²ç»åœ¨ä¸­å›½å¸®éæ´²çš„æ— æ•°ä¿®è·¯ã€æ¶æ¡¥ã€å‘ç”µã€æ°´åˆ©ç­‰é¡¹ç›®ä¸­è¯å®äº†ï¼Œåœ¨é¡¹ç›®çš„å®æ–½ä¸­ï¼Œè®¸å¤šæœ¬åœ°å·¥ç¨‹å¸ˆæˆé•¿äº†èµ·æ¥ã€‚å¯æ˜¯ï¼Œæ„¿æ„åœ¨éæ´²æˆäººä»¥æ¸”çš„åªæœ‰ä¸­å›½ç­‰ä¸å¤šçš„ä¸€äº›å›½å®¶ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@æ— è¾¹æ¡ƒç‚<!-- raw HTML omitted -->:â€‚å™—å“ˆå“ˆå“ˆå“ˆå“ˆï¼Œè¿™ä¸ªè§†é¢‘å¥½å¥½ç©ï¼šä¸€ä½ä¸­å›½è€æ¿å¨˜åœ¨éæ´²å¼€å‚ï¼Œéæ´²å‘˜å·¥ä»¬è¦å¥¹ç»™åšçº¢çƒ§è‚‰åƒï¼ˆç½‘ä¸Šçœ‹è§çš„çº¢çƒ§è‚‰ï¼Œå¾ˆå¥½å¥‡ï¼‰ï¼Œä¸€è·¯è¿˜é—®å„ç§é—®é¢˜ï¼šä¸ºä»€ä¹ˆè¦æ”¾æ°´ç…®ï¼Œæˆ‘ä»¬ç…®è‚‰ä¸æ”¾é‚£ä¹ˆå¤šæ°´ï¼Œä¹Ÿä¸æ”¾æ ‘å¶å­ï¼Œæˆ‘ä»¬å–èŒ¶çš„æ—¶å€™æ‰æ”¾ç³–â€¦â€¦æœ€åä¸€å‡ºé”…å°±è¢«æŠ¢å®Œäº†<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;a href=&ldquo;<a href="https://video.w">https://video.w</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oxtqrn5AW">ğŸ”»ä»Šå¤©çš„é»å·´å«©å¯»å‘¼æœºçˆ†ç‚¸è¢­å‡»çœŸæ˜¯ä»¤äººå°è±¡æ·±åˆ»ï¼Œå…¶å†›äº‹å’Œæ”¿æ²»æ•ˆæœæ¥è¿‘ 0ã€‚ğŸ”»çœŸä¸»å…šçš„å†›äº‹é¢†å¯¼å±‚æ²¡æœ‰ä¸€äººä¸§ ç”Ÿï¼Œåœ¨é‡ éš¾çš„ 9 äººä¸­ï¼Œå¤§éƒ¨åˆ†æ˜¯é»å·´å«©å¹³æ°‘ã€‚åœ¨...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oxtqrn5aw/">
    
    
    
    
    
      
    
    ğŸ”»ä»Šå¤©çš„é»å·´å«©å¯»å‘¼æœºçˆ†ç‚¸è¢­å‡»çœŸæ˜¯ä»¤äººå°è±¡æ·±åˆ»ï¼Œå…¶å†›äº‹å’Œæ”¿æ²»æ•ˆæœæ¥è¿‘ 0ã€‚<!-- raw HTML omitted -->ğŸ”»çœŸä¸»å…šçš„å†›äº‹é¢†å¯¼å±‚æ²¡æœ‰ä¸€äººä¸§ ç”Ÿï¼Œåœ¨é‡ éš¾çš„ 9 äººä¸­ï¼Œå¤§éƒ¨åˆ†æ˜¯é»å·´å«©å¹³æ°‘ã€‚åœ¨åŒ»é™¢çš„è§†é¢‘ä¸­ä¹Ÿçœ‹åˆ°äº†å¾ˆå¤šå—ä¼¤çš„å„¿ç«¥ã€‚ <!-- raw HTML omitted -->ğŸ”»ã€Šåç››é¡¿é‚®æŠ¥ã€‹æ´å¼•ä¸€ä¸ªå®‰å…¨æ™ºå›Šå›¢çš„è¯è¯´ï¼Œåœ¨é»å·´å«©å‘ç”Ÿçš„äº‹ä»¶æ˜¯å¤§è§„æ¨¡çš„ç”¨è£…æœ‰çˆ†ç‚¸ç‰©çš„è´§ç‰©æ›¿æ¢è¿›å£é€šè®¯è®¾å¤‡çš„ç»“æœï¼Œå¦ä¸€æ–¹é¢ï¼Œå®ƒå°†é»å·´å«©ä»¥åŠå…¨ä¸–ç•Œç»å¤§éƒ¨åˆ†å›½å®¶å¯¹â€œæŠ€æœ¯â€å’Œâ€œä¾›åº”é“¾â€çš„è­¦æƒ•æ€§æé«˜åˆ°äº†æœ€é«˜æ°´å¹³ã€‚<!-- raw HTML omitted -->ğŸ”»ä»¥è‰²åˆ— 14 é¢‘é“ç§°ï¼Œä»Šæ™šå°†å¼€å§‹æŠŠå®‰å…¨å’Œå†›äº‹é‡å¿ƒä»åŠ æ²™åœ°å¸¦è½¬ç§»åˆ°åŒ—éƒ¨å‰çº¿ï¼Œè¿™è¡¨æ˜ä»¥è‰²åˆ—æœ‰å¯èƒ½å¾ˆå¿«å®£å¸ƒåŒ—éƒ¨å‰çº¿ä¸ºä¸»æˆ˜çº¿ã€‚ç“¦æ‹‰ç½‘ç«™ç§°ï¼Œä»¥å†›é¢„å¤‡å½¹äººå‘˜å·²æ¥åˆ°ç«‹å³åŠ¨å‘˜çš„å‘½ä»¤ã€‚<!-- raw HTML omitted -->ğŸ”»é‚£ä½ æå‰ç‚¸ä»€ä¹ˆï¼Ÿ<!-- raw HTML omitted -->ğŸ”»è¿™æ˜¯ä¸€å¼ ç¾å›½ä»¤äººå°è±¡æ·±åˆ»çš„æ€æ‰‹é”ï¼Œè¢«ä»¥è‰²åˆ—åœ¨é”™è¯¯çš„æ—¶é—´æµªè´¹æ‰äº†ã€‚<!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E9%BB%8E%E5%B7%B4%E5%AB%A9%E5%A4%9A%E5%9C%B0%E6%97%A0%E7%25B">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E9%BB%8E%E5%B7%B4%E5%AB%A9%E5%A4%9A%E5%9C%B0%E6%97%A0%E7%B</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/OxmGPu948">è½‰ç™¼å¾®åš - è½¬å‘ @Dr-Erikaæ§˜:&amp;ensp;#ä¹…ä¿å²ç»ªé‡Œ# x #å¹³ç¥å¥ˆ# åŒä¸»æ¼”ã€çŸ³é»‘æ­£æ•°æ¼«ç”»ã€Šç¡è§‰çš„ç¬¨è›‹ã€‹çœŸäººç”µå½±åŒ–ï¼Œ 25å¹´æ˜¥å­£ä¸Šæ˜ ï¼Œå¯¼æ¼”ï¼šé˜ªå…ƒè£•å¾ã€‚æœ¬ä½œçš„ä¸»äººå…¬æ˜¯...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-oxmgpu948/">
    
    
    
    
    
      
    
    è½‰ç™¼å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@Dr-Erikaæ§˜<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->#ä¹…ä¿å²ç»ªé‡Œ#<!-- raw HTML omitted --><!-- raw HTML omitted --> x <!-- raw HTML omitted --><!-- raw HTML omitted -->#å¹³ç¥å¥ˆ#<!-- raw HTML omitted --><!-- raw HTML omitted --> åŒä¸»æ¼”ã€çŸ³é»‘æ­£æ•°æ¼«ç”»ã€Šç¡è§‰çš„ç¬¨è›‹ã€‹çœŸäººç”µå½±åŒ–ï¼Œ 25å¹´æ˜¥å­£ä¸Šæ˜ ï¼Œå¯¼æ¼”ï¼šé˜ªå…ƒè£•å¾ã€‚<!-- raw HTML omitted -->æœ¬ä½œçš„ä¸»äººå…¬æ˜¯ä½åœ¨å¤§å­¦å¥³ç”Ÿå®¿èˆåŒä¸€ä¸ªæˆ¿é—´çš„å…¥å·¢æŸšå®å’Œå¥¹çš„ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/Oxmxe5lvk">2025æ˜¥å­£ä¸Šæ˜ ï¼ [å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-oxmxe5lvk/">
    
    
    
    
    
      
    
    2025æ˜¥å­£ä¸Šæ˜ ï¼ <!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/OxpQdb0eS">//@å¤šæ¬¡å©‰æ‹’ä¹…ä¿ç»‡ç»‡:ğŸ“¢ğŸ“¢ğŸ“¢å†è¯´ä¸€é - è½¬å‘ @å¤šæ¬¡å©‰æ‹’ä¹…ä¿ç»‡ç»‡:&amp;ensp;æ¨ä¹…ä¿å²ç»ªé‡Œï¼Œè¿‡å°‘çˆ·ç”Ÿæ´»[è€å¸ˆçˆ±ä½ ] [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-oxpqdb0es/">
    
    
    
    
    
      
    
    //<!-- raw HTML omitted -->@å¤šæ¬¡å©‰æ‹’ä¹…ä¿ç»‡ç»‡<!-- raw HTML omitted -->:ğŸ“¢ğŸ“¢ğŸ“¢å†è¯´ä¸€é<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@å¤šæ¬¡å©‰æ‹’ä¹…ä¿ç»‡ç»‡<!-- raw HTML omitted -->:â€‚æ¨ä¹…ä¿å²ç»ªé‡Œï¼Œè¿‡å°‘çˆ·ç”Ÿæ´»<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->&lt;/bloc &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/Oxq0sbJ3y">éœéœåœ°çœ‹è‘—ä½  [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-oxq0sbj3y/">
    
    
    
    
    
      
    
    éœéœåœ°çœ‹è‘—ä½  <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/Oxt7CpRmq">å¤©ä½¿çš„æ—¥å¸¸ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-oxt7cprmq/">
    
    
    
    
    
      
    
    å¤©ä½¿çš„æ—¥å¸¸ <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OxmIqA9hj">ä¹…ä¿å²ç»ªé‡Œ ä¹…ä¿å²ç»ªé‡Œå°†æ‹…ä»»ç”µå½±ã€Œç¡è§‰çš„ç¬¨è›‹ï¼ˆãƒãƒ ãƒ«ãƒã‚«ï¼‰ã€çš„åŒä¸»æ¼”ï¼ ç”µå½±åŸä½œæ˜¯å› ã€Œå¥³ä»†å’–å•¡å…ï¼ˆãã‚Œã§ã‚‚ç”ºã¯å»»ã£ã¦ã„ã‚‹ï¼‰ã€ã€Œå¤©å›½å¤§é­”å¢ƒã€ç­‰å¤§çƒ­ä½œå“è€ŒçŸ¥...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oxmiqa9hj/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --> ä¹…ä¿å²ç»ªé‡Œå°†æ‹…ä»»ç”µå½±ã€Œç¡è§‰çš„ç¬¨è›‹ï¼ˆãƒãƒ ãƒ«ãƒã‚«ï¼‰ã€çš„åŒä¸»æ¼”ï¼ <!-- raw HTML omitted --><!-- raw HTML omitted -->ç”µå½±åŸä½œæ˜¯å› ã€Œå¥³ä»†å’–å•¡å…ï¼ˆãã‚Œã§ã‚‚ç”ºã¯å»»ã£ã¦ã„ã‚‹ï¼‰ã€ã€Œå¤©å›½å¤§é­”å¢ƒã€ç­‰å¤§çƒ­ä½œå“è€ŒçŸ¥åçš„çŸ³é»’æ­£æ•°æ°çš„åŒåæ¼«ç”»ã€‚è¯¥ä½œäº2008å¹´å‘å”®ï¼Œè™½ç„¶æ˜¯1å·å®Œç»“ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/Oxomywa7P">ä¹…ä¿å²ç»ªé‡Œ#shiorigram# .ç”µå½±ã€ç¡è§‰çš„ç¬¨è›‹ã€æˆ‘æœ‰å¹¸é¥°æ¼”å…¥å·¢æŸšå®ã€‚å’Œè¿™éƒ¨ä½œå“çš„ç›¸é‡æ˜¯å†²å‡»æ€§çš„ã€å‘½è¿ä¸€èˆ¬çš„ã€‚åº¦è¿‡äº†éš¾å¿˜çš„æ—¶é—´ã€‚é‚£æ—¶çš„å£°éŸ³ã€æ™¯è‰²å’Œäººéƒ½ç•™åœ¨æˆ‘å¿ƒ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oxomywa7p/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/Oxq3nAlZG">ä¹…ä¿å²ç»ªé‡Œ via.nhk_venue101 Xâœ¨#Venue101 è¦‹é€ƒã—é…ä¿¡ä¸­âœ¨ğŸ‘•#OOTD101ğŸ‘Ÿ#ä¹ƒæœ¨å‚46 ãŒç”Ÿæ”¾é€å½“æ—¥ã®è¡£è£…ã‚’ç´¹ä»‹ğŸ’œ#ãƒãƒ¼ãƒˆãƒ‡ã‚¤ ã«ã´ã£ãŸã‚Šãªçˆ½ã‚„ã‹ãªè¡£è£…ğŸ’ ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oxq3nalzg/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --> via.nhk_venue101 X<!-- raw HTML omitted -->âœ¨#Venue101 è¦‹é€ƒã—é…ä¿¡ä¸­âœ¨<!-- raw HTML omitted --><!-- raw HTML omitted -->ğŸ‘•#OOTD101ğŸ‘Ÿ<!-- raw HTML omitted --><!-- raw HTML omitted -->#ä¹ƒæœ¨å‚46 ãŒç”Ÿæ”¾é€å½“æ—¥ã®è¡£è£…ã‚’ç´¹ä»‹ğŸ’œ<!-- raw HTML omitted --><!-- raw HTML omitted -->#ãƒãƒ¼ãƒˆãƒ‡ã‚¤ ã«ã´ã£ãŸã‚Šãª<!-- raw HTML omitted -->çˆ½ã‚„ã‹ãªè¡£è£…ğŸ’ <!-- raw HTML omitted --><!-- raw HTML omitted -->ãƒ¡ãƒ³ãƒãƒ¼ã®å€‹æ€§ã«åˆã‚ã›ãŸã“ã ã‚ã‚Šã«æ³¨ç›®ã§ã™ğŸ‘—<!-- raw HTML omitted --><!-- raw HTML omitted -->NHKãƒ—ãƒ©ã‚¹ã§è¡£è£…ã‚‚checkğŸ‘‡<!-- raw HTML omitted -->plus. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/Oxqax7tfW">ä¹…ä¿å²ç»ªé‡Œ[è€¶] - è½¬å‘ @ä¹ƒæœ¨å‚46:&amp;ensp;ã€æ–°é—»æ›´æ–°ã€‘#ä¹…ä¿å²ç»ªé‡Œ# å°†æ‹…ä»»ç”µå½±ã€Šãƒãƒ ãƒ«ãƒã‚«ã€‹çš„åŒä¸»æ¼”ï¼ç½‘é¡µé“¾æ¥ä¹ƒæœ¨å‚46 [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oxqax7tfw/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/Oxr6hxH1B">ä¹…ä¿å²ç»ªé‡Œ via.nogizaka_goodsğŸ‘¼2024ä¸‡åœ£èŠ‚ğŸ‘¿ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oxr6hxh1b/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --> via.nogizaka_goods<!-- raw HTML omitted --><!-- raw HTML omitted -->ğŸ‘¼2024ä¸‡åœ£èŠ‚ğŸ‘¿ <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

</main>
</div>

<script async src="//yihui.name/js/center-img.js"></script>

<footer>

<div class="footer">
  <ul class="menu">
    
    <li><a href="/"><span data-hover="Home">Home</span></a></li>
    
    <li><a href="/about/"><span data-hover="About">About</span></a></li>
    
    <li><a href="/archives/"><span data-hover="Archive">Archive</span></a></li>
    
    <li><a href="/contributor/"><span data-hover="Contributor">Contributor</span></a></li>
    
    <li><a href="/index.xml"><span data-hover="Subscribe">Subscribe</span></a></li>
    
  </ul>
  
  <div class="copyright">Â© <a href="https://rainoffallingstar.github.io">Fallingstar</a> 2023 | <a href="https://github.com/rainoffallingstar">Github</a></div>
  
</div>
</footer>







</body>
</html>

